Schedule 13G ownership disclosure

Freeline Therapeutics Holdings plc

Security class unavailable · CUSIP: 35655L107

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,485,656
Percent of class
7.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001580642-21-000673
Form type
SC 13G
Filer
EVENTIDE ASSET MANAGEMENT, LLC
CIK
CIK 1442891
Filed
Feb 12, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub